To describe the prevalence of the L76V protease inhibitors resistance-associated mutation (PI-RAM) in relation with patients' characteristics and protease genotypic background in HIV-1 B- and "non-B"-infected patients.
Charpentier, C., Lambert Niclot, S., Alteri, C., Storto, A., Flandre, P., Svicher, V., et al. (2013). Description of the L76V resistance protease mutation in HIV-1 B and "non-B" subtypes. PLOS ONE, 8(1), e54381-e54381 [10.1371/journal.pone.0054381].
Description of the L76V resistance protease mutation in HIV-1 B and "non-B" subtypes
SVICHER, VALENTINA;PERNO, CARLO FEDERICO;CECCHERINI SILBERSTEIN, FRANCESCA;
2013-01-01
Abstract
To describe the prevalence of the L76V protease inhibitors resistance-associated mutation (PI-RAM) in relation with patients' characteristics and protease genotypic background in HIV-1 B- and "non-B"-infected patients.File in questo prodotto:
Non ci sono file associati a questo prodotto.
Questo articolo è pubblicato sotto una Licenza Licenza Creative Commons
